The Gateway Pundit by Cristina Laila
The Food and Drug Administration (FDA) will sharply restrict the use of two monoclonal antibody treatments according to a new report by the Washington Post.
According to WaPo, the Biden Administration is expected to halt distribution of monoclonal antibody treatments made by Regeneron Pharmaceuticals and Eli Lilly because they are âineffective against Omicron.â…
